Cellular Biomedicine Group Inc. is a biomedicine company that operates in Greater China and specializes in the treatment of cancerous and degenerative diseases. The company primarily focuses on developing and marketing cell-based therapies that target chronic and degenerative diseases, including cancer, osteoarthritis, various inflammatory diseases, and metabolic diseases. With a commitment to improving patient outcomes and enhancing the quality of life for those suffering from serious illnesses, Cellular Biomedicine Group Inc. is poised to make a significant impact on the healthcare industry in Greater China and beyond.